https://thevitalrecord.ai/2026/06/16/triple-drug-regimen-halves-progression-risk-in-hard-to-treat-myeloma/ The Vital Record en 2026-06-16T00:00:00.000Z Triple-Drug Regimen Halves Progression Risk in Hard-to-Treat Myeloma https://thevitalrecord.ai/2026/06/16/what-successor-2-tells-us-about-the-celmod-era-in-myeloma/ The Vital Record en 2026-06-16T00:00:00.000Z What SUCCESSOR-2 Tells Us About the CELMoD Era in Myeloma https://thevitalrecord.ai/2026/06/16/dpp-25-year-followup-lifestyle-cuts-multimorbidity-metformin-does-not/ The Vital Record en 2026-06-16T00:00:00.000Z At 25 Years, Lifestyle Cuts Multimorbidity Risk; Metformin Does Not https://thevitalrecord.ai/2026/06/16/ai-oct-grading-cuts-diabetic-macular-edema-false-referrals-45-points/ The Vital Record en 2026-06-16T00:00:00.000Z AI Grading Cuts False Referrals by 45 Points in Diabetic Macular Edema Screening https://thevitalrecord.ai/2026/06/16/abbvie-opens-pivotal-gene-therapy-trial-for-diabetic-retinopathy-naavi/ The Vital Record en 2026-06-16T00:00:00.000Z AbbVie Opens Pivotal Gene Therapy Trial for Diabetic Retinopathy https://thevitalrecord.ai/2026/06/16/nci-suspends-phase-3-cemiplimab-trial-resectable-skin-cancer/ The Vital Record en 2026-06-16T00:00:00.000Z NCI Suspends Phase 3 Cemiplimab Trial in Resectable Skin Cancer https://thevitalrecord.ai/2026/06/15/nara-organics-botulism-recall/ The Vital Record en 2026-06-15T00:00:00.000Z FDA and CDC Investigate Nationwide Voluntary Recall of Nara Organics Powdered Infant Formula After Three Infants Hospitalized With Botulism https://thevitalrecord.ai/2026/06/15/nara-organics-recall-when-epidemiology-outruns-the-lab/ The Vital Record en 2026-06-15T00:00:00.000Z The Nara Organics Recall: When Epidemiology Must Move Faster Than the Lab https://thevitalrecord.ai/2026/06/15/oceanic-af-asundexian-termination/ The Vital Record en 2026-06-15T00:00:00.000Z OCEANIC-AF Stopped Early for Inferior Efficacy After 14,830 Patients: What the Failure of This FXIa Inhibitor Means for Anticoagulation Research https://thevitalrecord.ai/2026/06/15/pph-lancet-series/ The Vital Record en 2026-06-15T00:00:00.000Z A Woman Dies of Postpartum Haemorrhage Every 12 Minutes. A Landmark Lancet Series Charts Why So Many Cases Are Still Being Missed — and What Must Change. https://thevitalrecord.ai/2026/06/15/intellia-lonvo-z-haelo-phase3/ The Vital Record en 2026-06-15T00:00:00.000Z Single-Dose Investigational CRISPR Therapy Cut HAE Attacks 87% in Phase 3 HAELO Trial, Company Reports https://thevitalrecord.ai/2026/06/15/llm-vs-clinical-ai-nature-medicine/ The Vital Record en 2026-06-15T00:00:00.000Z General-Purpose AI Outperforms Specialized Clinical Tools in Head-to-Head Benchmark https://thevitalrecord.ai/2026/06/15/empact-mi-empagliflozin-post-mi/ The Vital Record en 2026-06-15T00:00:00.000Z EMPACT-MI: Empagliflozin Falls Short on Primary Endpoint After Acute Heart Attack https://thevitalrecord.ai/2026/06/15/arpa-h-advocate-agentic-ai-cardiology/ The Vital Record en 2026-06-15T00:00:00.000Z ARPA-H Launches ADVOCATE to Fund Development of the First FDA-Authorized Autonomous AI System for Cardiovascular Care https://thevitalrecord.ai/2026/06/15/rad51d-xrcc2-saturation-genome-editing/ The Vital Record en 2026-06-15T00:00:00.000Z PREPRINT — NOT PEER REVIEWED: Saturation Genome Editing Characterizes Nearly All Variants in Two Cancer-Risk Genes, Supporting Future Clinical Classification